hBChE inhibitor

SI-7938

hBChE inhibitor, >98% (HPLC)

IUPAC Name : 2-(4-Ethoxybenzyl)-1-isopentyl-1H-benzo[d]imidazol-5-yl azetidine-1-carboxylate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is a benzimidazole carbamate dual‑acting ligand that combines hBChE inhibition with CB2 receptor activation to deliver complementary cholinergic and immunomodulatory neuroprotective effects. It shows balanced activity across both targets, modulates microglial activation, and exhibits favorable pharmacokinetics with brain penetration, positioning it as a promising dual‑mechanism neuroprotective lead.

References : Spatz P. et al.: J. Med. Chem., 66(9), 6414-6435, 2023.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.